Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Affiliierte Einheiten

CBmed Center for Biomarker Research in Medicine

SCI/PUBMED gelistet | alle Publikationstypen | Gesamt nach Jahr und Erstautor | MUG-Autor*innen |

** = Publikationen gelistet in SCI/SSCI/Pubmed

Originalarbeit (Zeitschrift)

** Labenz, J; Borkenstein, DP; Heil, FJ; Madisch, A; Tappe, U; Schmidt, H; Terjung, B; Klymiuk, I; Horvath, A; Gross, M; Stadlbauer, V Application of a multispecies probiotic reduces gastro-intestinal discomfort and induces microbial changes after colonoscopy
FRONT ONCOL. 2023; 12: 1078315 Doi: 10.3389/fonc.2022.1078315 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG


** Moser, O; Müller, A; Aberer, F; Aziz, F; Kojzar, H; Sourij, C; Obermayer, A; Abbas, F; Birnbaumer, P; Lenz, J; Mursic, I; Sternad, C; Hönger, L; Ziko, H; Pferschy, PN; Tripolt, N; Sourij, H Comparison of Insulin Glargine 300 U/mL and Insulin Degludec 100 U/mL Around Spontaneous Exercise Sessions in Adults with Type 1 Diabetes: A Randomized Cross-Over Trial (ULTRAFLEXI-1 Study).
Diabetes Technol Ther. 2023; Doi: 10.1089/dia.2022.0422
Web of Science PubMed FullText FullText_MUG


** Obermayer, A; Tripolt, NJ; Pferschy, PN; Kojzar, H; Aziz, F; Müller, A; Schauer, M; Oulhaj, A; Aberer, F; Sourij, C; Habisch, H; Madl, T; Pieber, T; Obermayer-Pietsch, B; Stadlbauer, V; Sourij, H Efficacy and Safety of Intermittent Fasting in People With Insulin-Treated Type 2 Diabetes (INTERFAST-2)-A Randomized Controlled Trial.
Diabetes Care. 2023; 46(2):463-468 Doi: 10.2337/dc22-1622 [OPEN ACCESS]
PubMed PUBMED Central FullText FullText_MUG


** Stadlbauer, V Liver-Gut-Interaction: Role of Microbiome Transplantation in the Future Treatment of Metabolic Disease
J PERS MED. 2023; 13(2): 220 Doi: 10.3390/jpm13020220 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG



** Sourij, C; Aziz, F; Kojzar, H; Obermayer, AM; Sternad, C; Müller, A; Tripolt, NJ; Pferschy, PN; Aberer, F; Schlenke, P; Kleinhappl, B; Stradner, M; Sareban, N; Moritz, M; Dominguez-Villar, M; Oliver, N; Steinmetz, I; Sourij, H Severe acute respiratory syndrome coronavirus 2 spike antibody level decline is more pronounced after the second vaccination, but response to the third vaccination is similar in people with type 1 and type 2 diabetes compared with healthy controls: The prospective COVAC-DM cohort study.
Diabetes Obes Metab. 2023; 25(1): 314-318. Doi: 10.1111/dom.14855 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG


© Med Uni Graz Impressum